JENNIFER SAMPSON: Open Payments
NPI 1124530449 · EAST JORDAN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$981 in 53 payments from 14 companies in 2025. Trend: 2023 $13 · 2024 $207 · 2025 $981
Food & beverage: $912Education: $69
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $249 |
| ABBVIE INC. | 16 | $244 |
| Astellas Pharma US Inc | 6 | $148 |
| Novo Nordisk Inc | 3 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| Axsome Therapeutics, Inc. | 4 | $65 |
| Lundbeck LLC | 1 | $22 |
| Corcept Therapeutics | 1 | $18 |
| Amgen Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: UBRELVY, VRAYLAR, Veozah, FARXIGA, CAPLYTA, BREZTRI, QULIPTA, Auvelity.
Industry payments across MI — which companies pay providers there.
